Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Multiplex testing for Factor II and Factor V mutations in thrombophilia: technical verification and clinical validation of the cobas® Factor II and Factor V test.

Longshore JW, DeMartin K, Yu K, Das P, Zhang G, Rehage TT, Jethwaney D, Karwowska S.

J Thromb Thrombolysis. 2019 Jan;47(1):87-95. doi: 10.1007/s11239-018-1745-8.

2.

Immune cell subsets and their gene expression profiles from human PBMC isolated by Vacutainer Cell Preparation Tube (CPT™) and standard density gradient.

Corkum CP, Ings DP, Burgess C, Karwowska S, Kroll W, Michalak TI.

BMC Immunol. 2015 Aug 26;16:48. doi: 10.1186/s12865-015-0113-0.

3.

Differential expression of interferon alpha inducible genes in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus and healthy donors.

MacParland SA, Corkum CP, Burgess C, Karwowska S, Kroll W, Michalak TI.

Int Immunopharmacol. 2015 Apr;25(2):545-52. doi: 10.1016/j.intimp.2015.02.037. Epub 2015 Mar 10.

PMID:
25765354
4.

Single-dose pharmacokinetics, safety, and tolerability of albinterferon alfa-2b in subjects with end-stage renal disease on hemodialysis compared to those in matched healthy volunteers.

Serra DB, Sun H, Karwowska S, Praestgaard J, Halabi A, Stein DS.

Antimicrob Agents Chemother. 2011 Feb;55(2):473-7. doi: 10.1128/AAC.00626-10. Epub 2010 Nov 22.

5.

Telbivudine exhibits no inhibitory activity against HIV-1 clinical isolates in vitro.

Lin K, Karwowska S, Lam E, Limoli K, Evans TG, Avila C.

Antimicrob Agents Chemother. 2010 Jun;54(6):2670-3. doi: 10.1128/AAC.01703-09. Epub 2010 Mar 22.

6.

Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System.

van Helden J, Denoyel G, Karwowska S, Reamer R, Schmalz J, Wright T, Preisel-Simmons B.

Clin Lab. 2004;50(1-2):63-73.

PMID:
15000222
7.

Induction of HIV type 1 neutralizing and env-CD4 blocking antibodies by immunization with genetically engineered HIV type 1-like particles containing unprocessed gp160 glycoproteins.

Rovinski B, Rodrigues L, Cao SX, Yao FL, McGuinness U, Sia C, Cates G, Zolla-Pazner S, Karwowska S, Matthews TJ, et al.

AIDS Res Hum Retroviruses. 1995 Oct;11(10):1187-95.

PMID:
8573374
8.

Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1.

Gorny MK, Moore JP, Conley AJ, Karwowska S, Sodroski J, Williams C, Burda S, Boots LJ, Zolla-Pazner S.

J Virol. 1994 Dec;68(12):8312-20.

9.

Synergistic neutralization of human immunodeficiency virus type 1 by combinations of human monoclonal antibodies.

Laal S, Burda S, Gorny MK, Karwowska S, Buchbinder A, Zolla-Pazner S.

J Virol. 1994 Jun;68(6):4001-8.

10.

Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120.

Gorny MK, Xu JY, Karwowska S, Buchbinder A, Zolla-Pazner S.

J Immunol. 1993 Jan 15;150(2):635-43.

PMID:
7678279
11.

Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody.

Gorny MK, Conley AJ, Karwowska S, Buchbinder A, Xu JY, Emini EA, Koenig S, Zolla-Pazner S.

J Virol. 1992 Dec;66(12):7538-42.

12.

Amino acid residues of the human immunodeficiency virus type I gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction.

McKeating JA, Thali M, Furman C, Karwowska S, Gorny MK, Cordell J, Zolla-Pazner S, Sodroski J, Weiss RA.

Virology. 1992 Sep;190(1):134-42.

PMID:
1382339
13.

Synergy between human monoclonal antibodies to HIV extends their effective biologic activity against homologous and divergent strains.

Buchbinder A, Zolla-Pazner S, Karwowska S, Gorny MK, Burda ST.

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1395. No abstract available.

PMID:
1466965
14.

Production of human monoclonal antibodies specific for conformational and linear non-V3 epitopes of gp120.

Karwowska S, Gorny MK, Buchbinder A, Gianakakos V, Williams C, Fuerst T, Zolla-Pazner S.

AIDS Res Hum Retroviruses. 1992 Jun;8(6):1099-106.

PMID:
1380257
15.

Synergy between human monoclonal antibodies to HIV extends their effective biologic activity against homologous and divergent strains.

Buchbinder A, Karwowska S, Gorny MK, Burda ST, Zolla-Pazner S.

AIDS Res Hum Retroviruses. 1992 Apr;8(4):425-7. No abstract available.

PMID:
1599752
17.

Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein.

Gorny MK, Xu JY, Gianakakos V, Karwowska S, Williams C, Sheppard HW, Hanson CV, Zolla-Pazner S.

Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3238-42.

18.

Passive immunization for the treatment and prevention of HIV infection.

Karwowska S, Zolla-Pazner S.

Biotechnol Ther. 1991;2(1-2):31-48. Review.

PMID:
1845123
19.

Expression of multivalent pre-S1 antigen of hepatitis B virus in Escherichia coli (synthetic oligodeoxynucleotides, surface antigens, recombinant DNA, fusion protein, beta-galactosidase).

Sidorkiewicz M, Jaworski J, Płucienniczak G, Płucienniczak A, Stpień P, Kalinowska B, Karwowska S, Nowosławski A, Uznański B, Wilk A, et al.

Arch Immunol Ther Exp (Warsz). 1991;39(4):357-64.

PMID:
1821612
20.

[Incidence of HIV infection among homosexuals].

Weyman-Rzucidło D, Mazurkiewicz W, Ochelska B, Karnyska-Trypens M, Owsińska H, Kalinowska B, Karwowska S, Stapiński A.

Przegl Dermatol. 1989 Jul-Aug;76(4):317-21. Polish.

PMID:
2631138
21.

[Serologic indicators of the preventive activity of gamma globulin produced by the Warsaw Laboratory of Sera and Vaccines in 1972-1984 against viral hepatitis].

Karwowska S, Kacperska E, Seyfried H, Nowosławski A.

Przegl Epidemiol. 1986;40(2):193-9. Polish. No abstract available.

PMID:
2433711
22.

[Clinical aspects of post-transfusion non-A, non-B hepatitis].

Januszkiewicz J, Brykczyńska H, Karwowska S, Krawczyński K.

Pol Tyg Lek. 1985 Mar 18;40(11):337-40. Polish. No abstract available.

PMID:
3923456
23.
24.

Isolation and characterization of liver-derived hepatitis B e antigen.

Budkowska A, Petit MA, Karwowska S, Roszuk D.

J Med Virol. 1984;13(3):269-79.

PMID:
6726192
25.

Etiopathogenetic aspects of hepatitis A II. Specific and nonspecific humoral immune response during the course of infection.

Slusarczyk J, Hansson BG, Nordenfelt E, Krawczyński K, Karwowska S, Knap J.

J Med Virol. 1984;14(3):269-76.

PMID:
6502142
26.

[Case of post-transfusion viral hepatitis of the non-A, non-B type].

Knap J, Karwowska S.

Pol Tyg Lek. 1982 Oct 25;37(40):1209-10. Polish. No abstract available.

PMID:
6819554
27.

Enzyme immunoassay for the detection of hepatitis B virus core antigen.

Budkowska A, Karwowska S.

J Immunol Methods. 1982;51(3):341-6.

PMID:
7108233

Supplemental Content

Loading ...
Support Center